Genetic control of immune responses to HIV-1 env DNA vaccine.
We investigated the genetic control of immunoglobulin production and the delayed-type hypersensitivity (DTH) response produced by an HIV-specific DNA vaccine using several strains of mice. Murine antigen-specific immunoglobulin production was determined by ELISA. The DTH response was assessed in terms of the footpad swelling reaction. All strains of mice, except for B10.RIII and B10.T(6R), exhibited strong immunoglobulin production and footpad swelling in response to the DNA vaccine. In vitro treatment of lymphoid cells with monoclonal antibodies showed that the footpad swelling response was mediated by CD4+8- and Ia- T cells. However, CD8+ T cells did not suppress footpad swelling. There was no difference in the induction of HIV-specific immunoglobulin production or DTH response induced by the DNA vaccine among the strains, suggesting that HIV-specific DNA vaccine is useful for immunizing various populations against HIV-1.
Ishii
N
N
Department of Dermatology, Yokohama City University School of Medicine, Kanagawa, Japan.
Sugita
Y
Y
Nakajima
H
H
Bukawa
H
H
Asakura
Y
Y
Okuda
K
K
D016915:AIDS Vaccines / Q000276:immunology*; D019264:Adoptive Transfer; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D015752:Genes, env; D006183:H-2 Antigens / Q000276:immunology*; D015483:HIV Antibodies / Q000096:biosynthesis*; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D006801:Humans; D006968:Hypersensitivity, Delayed; D008198:Lymph Nodes / Q000166:cytology / Q000276:immunology; D051379:Mice; D019444:Vaccines, DNA / Q000276:immunology*
D016915:AIDS Vaccines; D000911:Antibodies, Monoclonal; D006183:H-2 Antigens; D015483:HIV Antibodies; D019444:Vaccines, DNA